This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
Biogen stock jumped on Wednesday after a South Korean newspaper reported that Samsung Group was in talks to acquire the drugmaker.
A Samsung spokesperson told Barron’s in an emailed statement that the report was groundless.
The Korea Economic Daily, citing unnamed investment banking sources, reported that Samsung is engaged in negotiations…